Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Aromatase Inhibitor
Related studies linked through entity extraction aliases.
Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Dendritic Cell Based Therapy for Breast Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
- Status
- COMPLETED
- Phase
- PHASE4